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A family suffering from Refsum disease,' the first to be discovered in the British
Isles, was identified in 1957. One brother and two sisters were affected, while the
second brother remained unaffected.2 The propositus James (JS) presented in
1953 at the age of 21 with an acute polyneuropathy and raised CSF protein
(4.5 g/l). His married sister aged 23 died a few weeks aftershe wasfirst examined
in 1957 from an acute encephalomyelitis with raised CSF protein (6.0 g/l). The
younger sister Kathleen (KG) aged 20 had no complaints and the CSF was
normal in 1957. All showed the characteristic featuresofRefsum disease, retinitis
pigmentosa with night blindness and constriction of the visual fields, skeletal
abnormalities and ichthyosis. James and Kathleen pursued a relapsing remitting
course and slowly deteriorated despite treatment with steroids during relapses. At
the request of Professor Daniel Steinberg now ofthe University of California, San
Diego, they were transferred to the National Institute of Health at Bethesda,
Maryland, USA, in 1966 for further investigation and dietary treatment. Their
neurological state on admission to the NIH was described by Steinberg et al.3 and
their initial treatment and progress by Kark et al.4 This paper is concerned with
their further progress since their return to Northern Ireland in May 1970. They
were then receiving a very strict low phytol, low phytanic acid fluid diet.
CASE 1
KG: Kathleen remained well, and she married in 1973. She was able to look
after her house and go shopping. Her visual acuity was N12 N12 and weight
12 st. 1 lb. In 1975 a cataract developed in the right eye which was extracted in
June 1976. Postoperative glaucoma developed and the visual acuity was 6/60
6/60. In August 1976 she complained of nausea and anorexia, probably due to
acetazolamide treatment for glaucoma. Her weight fell to 8 st. 1 lb. Visual acuity
was limited to hand movements. She developed a urinary tract infection with
coliform organisms which wassuccessfully treated. Blood pressure was 140/100
mm Hg. Twenty-four hour urine protein was 0.1 g in 1560 ml. Serum urea was
19.9 mmol/l, creatinine 250 pumol/l and calcium 2.24 mmol/l. Intravenous
pyelogram showed small kidneys with blunted calyces suggesting chronic
pyelonephritis. X-ray chest and electrocardiograph were normal.
In 1977 she was able to do her housework and read headlines in newspapers.
There were no urinary symptoms apart from occasional nocturia. Unfortunately,
major epileptic fits developed, without an aura orfocal onset, and carbamazepine
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treatment 200 mg daily was started. By 1979 the dosage of carbamazepine was
increased to 300 mg daily because ofcontinued fits. A left cataract was extracted.
Her skull x-ray was normal but her EEG showed a sharp wave focus in the right
parietal region. Serum urea had risen to 34.5 mmol/l and creatinine to 580
pmol/l. Serum calcium was 2.41 mmol/l and alkaline phosphatase 108 units/I.
In January 1980 she had a further fit. Her weight remained 8 st. 1 lb. She was
able to smell only very pungent odours. Visual acuity in the right eye was limited
to hand movements, left eye 6/36 and she could read with a magnifying glass.
The right cornea was hazy, the left clear. She used a hearing aid. Power in the
arms was good with slight weakness of dorsiflexion of the fingers. There was
slight wasting of the forearms and small muscles of the hands. Power in the legs
was good except for movements at the ankles, and co-ordination was good.
Tendon reflexes were present, apart from the anklejerks, and the plantar reflexes
were flexor. All forms of sensation were normal. With the help of leg calipers she
had a high steppage gait, slightly wide-based and ataxic but surprisingly good
considering her poor vision and marked weakness at the ankles. The dryness of
her skin was improved. A CAT brain scan was normal. The haemoglobin was
10.4 g/dl and urine culture was sterile. Serum urea was 35.9 mmol/l, creatinine
557 pmol/l, calcium 2.18 mmol/l and alkaline phosphatase 794 units/l.
In view of her deteriorating condition and rising plasma phytanic acid level
(Figure) it was decided to try the effect of plasmapheresis. Between January and
July 1980 1 1 two-litre exchanges were carried out. Following this she felt slightly
better and the plasma phytanic acid level fell dramatically. Nerve conduction in
the right ulnar nerve improved from 25 to 31 m/sec, and in the right median
nerve from 28 to 30 in/sec. There was no change in renal function, serum urea
34.5 mmol/l, creatinine 639 pmol/l and calcium 2.07 mmol/l. Carbamazepine
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FIGURE. The figure shows the plasma phytanic acid values in Cases 1 and 2 from 1975. Prior to
dietary treatment, the highest value in Case 1 had been 75 mg/dl, and in Case 2 had been 55 mg/dl.
Note the fall in the phytanic acid value in Case 1 following plasmapheresis.
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In spite of this initial improvement she steadily deteriorated. She was admitted to
the South Tyrone Hospital on numerous occasions because of an increasing
number of major fits and generalised myoclonus. In October 1980 blood
pressure was 145/100 mm Hg, serum urea 36 mmol/l, creatinine 651 pmol/l,
calcium 1.75 mmol/l and alkaline phosphatase 100 units/I. Haemoglobin was
1 1.5 g/dl. In January 1981 she was admitted with a pyrexial illness, vomiting, fits
and myoclonus. Haemoglobin had fallen to 5.9 g/dl, but rose following
transfusion to 13.6 g/dl. Blood pressure was 160/100 mm Hg. Visual acuity was
limited to hand movements in the right eye and was 6/24 in the left eye.
Myoclonus was unaffected by intravenous calcium or bycholecalciferol. Aurinary
tractinfection withcoliform organismswastreated with ampicillin. Carbamazepine
1000 mg daily and diazepam 15 mg daily were required for epilepsy and
myoclonus.
She died on 14 February 1981. Autopsy was carried out by Dr R Lyness
(A 36278). Both kidneys were markedly reduced in size. There was a large
abscess in the upper pole of the right kidney measuring 6 cm in diameter
containing green pus. The cortex and medulla were destroyed. In the lower pole
there was a small cavity containing black brackish fluid. The cortex and medulla
were reduced at the lower pole. The lower pole of the left kidney had a cavity
containing black fluid and soft debris. The remainder of the cortex and medulla
contained some small cysts. The pelves, ureters and bladder were normal.
Histologicalsectionsshowed sclerosed glomeruli, andfociofchronicinflammation
in the interstitium. The residual glomeruli and tubules were unremarkable on
routine staining. More specific staining showed accumulated fat within the tubule
lining cells and within the lumen of the tubules. There was a wide spectrum of
fatty infiltration with some cells containing scant fine droplets and others
disturbed by fat. One section showed a cyst filled with old blood. Other organs
did not show this increase in fatty infiltration.
The brain showed no focal lesion to account for the epilepsy and myoclonus.
Spinal cord sections showed loss of posterior column fibres with decreased
staining of myelin. The posterior spino-cerebellar tracts showed a slight decrease
in staining indicating some fibre loss. The anterior horn cells were normal and
fhere was thickening of the anterior roots. Staining for fat showed increased
thickness of the myelin sheaths, some of which took up the stain to give a purple
hue. Peripheral nerve sections showed hypertrophy with hyperplasia and hyper-
cellularity of the Schwann cell coating of the axons. There was an increase in the
amount of endoneural tissue. Longitudinal sections showed a degree of




11 Section shows a loss of nerve fibres with increase of tissue in the
endoneural space. The eyes have yet to be processed.
III-VII Sections show slight patchy loss of myelinated fibres.
Vill Sections show loss of nerve fibres and myelin, gliosis and
corpora amylacia.
IX-XI Sections show proliferation of the Schwann cells to give thicken.
ing of the nerve fibres.
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The cause of the epilepsy was not clear. There was no lesion in the brain to
account for the focal EEG abnormality, but no doubt the chronic uraemia and low
serum calcium played a part.
The cause of death was septicaemia secondary to a coliform abscess in the right
kidney. The chronic progressive renal failure was probably due to chronic
pyelonephritis. What part the fatty deposits in the kidney (probably phytanic acid)
had to play is difficult to assess, but, as similar changes had been found in the
kidneys of another patient from a second Belfast family suffering from Refsum
disease who died in uraemia,5 further studies were performed. Thin layer chroma-
tography was carried out by Dr D McCormick on lipid extracts of liver, kidney,
heart, skeletal muscle and brain (frozen unfixed tissue). All these tissues except
brain showed an extra fraction which migrated ahead of the main triglyceride
fractions and which was absent from control samples, similar to the findings in the
case mentioned above.
CASE 2
JS: James was very well when he returned from Bethesda in 1970. He could
walk 5 miles but he was completely anosmic and deaf. His visual acuity was 6/60
in the right eye and he could only perceive light with the left eye.
In January 1974 he suffered a relapse following an attack of diarrhoea. Walking
became worse and he was unable to walk outside without assistance although he
could get around the house. He had difficulty tying laces and buttoning his shirt
but could feed himself. There was slight weakness of extension at both elbow and
wrist joints, weakness of all finger movements, particularly of the right thumb,
and moderate weakness at both knee and ankle joints. Light touch and pain
sensation was impaired in the hands and the lower third of both legs. Vibration
sensation was absent in the legs but joint position sense was normal. All the
tendon reflexes were absent apart from the biceps jerks. Cerebro-spinal fluid
protein concentration was 3.40 g/l. Conduction velocity in the right ulnar nerve
was 1 1.1 m/sec. and plasma phytanic acid was 13.9 mg/dl. Following a course
of ACTH injections forseveral months, power and sensation improved
considerably. CSF protein fell to 1.58 g/l and conduction velocity in the right
ulnar nerve rose to 17.3 m/sec.
In December 1974 he felt well and had become married. A normal daughter was
born in 1975. (Her plasma phytanic acid level was within normal limits in 1982).
In 1980 he began to complain of a 'buzzing noise' in the head for which no cause
could be found apart from deafness. He was able to walk 3 miles. Apart from
weakness at the ankles, power and co-ordination of the limbs was very good.
Sensation had improved except for persistent impairment of pain sensation in the
lower third of both legs. All the tendon reflexes were present apart from the ankle
jerks. Serum urea was 7.2 mmol/l and calcium 2.46 mmol/l. Urine contained a
trace of protein but was sterile. Conduction velocity in the right ulnar nerve was
now 30.8 m/sec.
Now, in 1984, James keeps well but complains still of the 'buzzing' noise in the
head. His daughter is normal in all respects. His plasma phytanic acid levels have
been satisfactory, varying from 12.1 to 33.0 mg/dl during the past two years.
Serum urea is 13 mmol/l, creatinine 103 pmol/l and calcium 2.44 mmol/l. The
unaffected brother is alive and well.
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DISCUSSION
There is little doubt that the dietary treatment led to considerable improvement in
mobility, power, co-ordination, sensation and peripheral nerve conduction in
both cases. There was also marked improvement in the ichthyotic condition of
the skin. It should be pointed out that Case 1 was in a wheelchair before the diet
was started. However, no clear-cut improvement could be shown in the special
senses of smell, vision and hearing in these two patients. Gibberd and Goldman9
have also reported disappointing results for the special senses. Perhaps dietary
treatment did not begin early enough. The striking improvement with ACTH
treatment forthe relapse in Case 2 in 1974 raisesthe possibility that disturbances
of an immunological nature can occur in the relapsing remitting type of the
disease.
Plasmapheresis has been successfully used in several cases of Refsum disease,
reducing the level of plasma phytanic acid.6,7.8 This treatment certainly caused a
dramatic fall in phytanic acid level in Case 1 but could it have contributed to her
death from renal abscess and septicaemia? Wing and his colleagues10 state that
one-third of patients undergoing plasmapheresis for renal disease will develop a
serious infection. They also found that each plasma exchange removes approx-
imately 30 per cent of serum immunoglobulin and 30 per cent of circulating
complement components when plasma is replaced with fresh-frozen plasma and
albumin in a 1 :1 ratio.
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